Tri-Lo-Sprintec (norgestimate and ethinyl estradiol) tablets USP recall

Why it was recalled

Failed Dissolution Specifications

Details

Product

Tri-Lo-Sprintec (norgestimate and ethinyl estradiol) tablets USP - triphasic regimen, packaged in carton containing 3 Blister Cards, 28 Tablets Each, Rx only, Teva Pharmaceuticals USA, INC, North Wales, PA 19454, NDC 0093-2140-62

Recalling company

Teva Pharmaceuticals USA, Inc.

Classification

Class II

Status

Terminated

Type

Voluntary: Firm initiated

Distribution

USA nationwide.

Initiated

Mar 7, 2024

FDA report date

Apr 3, 2024